Literature DB >> 1586246

Antibodies to protein P in systemic lupus erythematosus.

L S Teh1, A E Bedwell, D A Isenberg, C Gordon, P Emery, P J Charles, M Harper, N Amos, B D Williams.   

Abstract

A synthetic peptide was used to develop an enzyme linked immunosorbent assay (ELISA) to detect antibodies to the ribosomal proteins P0, P1, and P2. Significantly increased levels of IgG antibodies to protein P were found in 16% (18/116) of patients with systemic lupus erythematosus but slightly increased levels were detected in 2% (2/98) of patients with rheumatoid arthritis and one normal control subject. No association was observed between the presence of IgG antibodies to protein P and either lupus psychosis or depression. Sequential studies in individual patients failed to show an association between antibody levels and the development of psychosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1586246      PMCID: PMC1004698          DOI: 10.1136/ard.51.4.489

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  24 in total

Review 1.  The natural history of systemic lupus erythematosus by prospective analysis.

Authors:  D Estes; C L Christian
Journal:  Medicine (Baltimore)       Date:  1971-03       Impact factor: 1.889

2.  Cerebral lupus erythematosus.

Authors:  O Appenzeller; R C Williams
Journal:  Ann Intern Med       Date:  1979-03       Impact factor: 25.391

3.  A prospective study on antiribosomal P proteins in two cases of familial lupus and recurrent psychosis.

Authors:  R H Derksen; A P van Dam; F H Gmelig Meyling; J W Bijlsma; R J Smeenk
Journal:  Ann Rheum Dis       Date:  1990-10       Impact factor: 19.103

4.  Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis.

Authors:  P Lee; M B Urowitz; A A Bookman; B E Koehler; H A Smythe; D A Gordon; M A Ogryzlo
Journal:  Q J Med       Date:  1977-01

5.  Mortality in systemic lupus erythematosus: the bimodal pattern revisited.

Authors:  L A Rubin; M B Urowitz; D D Gladman
Journal:  Q J Med       Date:  1985-04

6.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

7.  An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus.

Authors:  B Bresnihan; M Oliver; B Williams; G R Hughes
Journal:  Arthritis Rheum       Date:  1979-04

Review 8.  Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease.

Authors:  E J Feinglass; F C Arnett; C A Dorsch; T M Zizic; M B Stevens
Journal:  Medicine (Baltimore)       Date:  1976-07       Impact factor: 1.889

9.  Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus.

Authors:  A B Schneebaum; J D Singleton; S G West; J K Blodgett; L G Allen; J C Cheronis; B L Kotzin
Journal:  Am J Med       Date:  1991-01       Impact factor: 4.965

10.  Association between lupus psychosis and anti-ribosomal P protein antibodies.

Authors:  E Bonfa; S J Golombek; L D Kaufman; S Skelly; H Weissbach; N Brot; K B Elkon
Journal:  N Engl J Med       Date:  1987-07-30       Impact factor: 91.245

View more
  13 in total

1.  Detection of asymptomatic cranial neuropathies in patients with systemic lupus erythematosus and their relation to antiribosomal P antibody levels and disease activity.

Authors:  Wafaa Gaber; Yasser Ezzat; Neveen M El Fayoumy; Hanan Helmy; Abeer M Mohey
Journal:  Clin Rheumatol       Date:  2014-05-24       Impact factor: 2.980

2.  The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease.

Authors:  A G Tzioufas; N G Tzortzakis; E Panou-Pomonis; K A Boki; M Sakarellos-Daitsiotis; C Sakarellos; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  2000-02       Impact factor: 19.103

3.  Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET.

Authors:  S M Weiner; A Otte; M Schumacher; R Klein; J Gutfleisch; I Brink; P Otto; E U Nitzsche; E Moser; H H Peter
Journal:  Ann Rheum Dis       Date:  2000-05       Impact factor: 19.103

4.  Antibodies against ribosomal phosphoprotein P0 of Plasmodium falciparum protect mice against challenge with Plasmodium yoelii.

Authors:  S Chatterjee; S Singh; R Sohoni; N J Singh; A Vaidya; C Long; S Sharma
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

5.  Endogenous type-I interferon activity is not associated with depression or fatigue in systemic lupus erythematosus.

Authors:  Erinn S Kellner; Pui Y Lee; Yi Li; Juliana Switanek; Haoyang Zhuang; Mark S Segal; Eric S Sobel; Minoru Satoh; Westley H Reeves
Journal:  J Neuroimmunol       Date:  2010-04-22       Impact factor: 3.478

6.  Association of anti-ribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus.

Authors:  Ahmed M Abdel-Nasser; Rasha M Ghaleb; Jehan A Mahmoud; Wafaa Khairy; Refaat M Mahmoud
Journal:  Clin Rheumatol       Date:  2008-05-15       Impact factor: 2.980

Review 7.  Systemic lupus erythematosus: immunopathogenesis of neurologic dysfunction.

Authors:  P M Moore; R P Lisak
Journal:  Springer Semin Immunopathol       Date:  1995

8.  Neuropsychiatric systemic lupus erythematosus.

Authors:  Alexandra Popescu; Amy H Kao
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

9.  A 17-year-old female with systemic lupus presents with complex movement disorder: possible relationship with antiribosomal p antibodies.

Authors:  Muhammed Emin Ozcan; Meriç Adil Altınöz; Hasan Hüseyin Karadeli; Talip Asil; Abdulkadir Koçer
Journal:  Case Rep Neurol Med       Date:  2013-05-08

Review 10.  Are anti-ribosomal P protein antibodies relevant in systemic lupus erythematosus?

Authors:  Emese Kiss; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2007-02       Impact factor: 10.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.